Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
about
Aldosterone antagonists for preventing the progression of chronic kidney diseaseAldosterone antagonists for preventing the progression of chronic kidney diseaseSupramaximal dose of candesartan in proteinuric renal diseaseAddition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathyRecent advances in managing and understanding diabetic nephropathyProteomics for prediction of disease progression and response to therapy in diabetic kidney diseaseDrug Targets for Oxidative Podocyte Injury in Diabetic NephropathyAssessing the Validity of Surrogate Outcomes for ESRD: A Meta-AnalysisPresent and future in the treatment of diabetic kidney diseaseMonitoring kidney function and albuminuria in patients with diabetes.Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A ReviewImprovements in the Management of Diabetic NephropathyRenal autoregulation in health and diseaseThe endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathyInvolvement of endoplasmic reticulum stress in albuminuria induced inflammasome activation in renal proximal tubular cellsCombined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic DisordersThe relationship between proteinuria and coronary risk: a systematic review and meta-analysisAldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.Grape seed powder improves renal failure of chronic kidney disease patients.Paeoniflorin prevents diabetic nephropathy in rats.Strategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney diseaseTryptophan Metabolism in Patients With Chronic Kidney Disease Secondary to Type 2 Diabetes: Relationship to Inflammatory Markers.Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort study.Comparison of spironolactone and trichlormethiazide as add-on therapy to renin-angiotensin blockade for reduction of albuminuria in diabetic patientsDual blockade of the renin-angiotensin system in diabetic nephropathy.Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitorsAvosentan for overt diabetic nephropathy.Proteinuria, (99m) Tc-DTPA Scintigraphy, Creatinine-, Cystatin- and Combined-Based Equations in the Assessment of Chronic Kidney Disease.Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 ratAmiloride as an Alternate Adjuvant Antiproteinuric Agent in Fabry Disease: The Potential Roles of Plasmin and uPAR.Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease.Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysisOptimal proteinuria target for renoprotection in patients with IgA nephropathy.Prevalence of microalbuminuria and risk factor analysis in type 2 diabetes patients in Albania: the need for accurate and early diagnosis of diabetic nephropathy.Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBModerate antiproteinuric effect of add-on aldosterone blockade with eplerenone in non-diabetic chronic kidney disease. A randomized cross-over study.Comparison of different measures of urinary protein excretion for prediction of renal events.Implementation of a CKD checklist for primary care providersHypertensive nephropathy: prevention and treatment recommendations.
P2860
Q24194979-8218CECE-86AE-4C0B-B636-6A1F5CCEDC6EQ24239909-0FDF308B-D806-4369-92EE-CE2C2785F879Q24649685-EA4B98F3-8D51-41E0-95AA-21F2EF608CAFQ24657470-FA50E300-3465-44AF-AD33-FB32206696EAQ26745900-C27DF4FF-120B-4930-8DB2-B819D41D99BAQ26747131-AC378A5D-BC4E-4819-9014-D9284B163F1AQ26769787-D857AB22-75BC-4097-8EC9-002ADBDFD643Q26863404-A5E23A47-EB03-4A55-AB9B-58DE0AAF24D4Q26864133-E85BA33C-915C-4AD8-A511-0CAAD2AE4587Q27691297-EB97664A-E9B8-4D86-AA73-980B07BC2507Q28079134-59A78A5C-45A2-4C61-80A4-CDB05D30FE93Q28080717-A2EE5D3E-3C9A-41E5-AD72-E46BCFACEA0FQ28082365-8C91B2EB-0933-47A3-AEE2-020E348C6C36Q28237978-D24CE244-444D-4888-BEAE-F6BB07F56393Q28535453-10B3EFE8-162C-4536-B82E-F0B9364A073DQ33166521-580BE170-F68B-46FF-93C1-618FFE1889A9Q33378672-A91F6950-6D05-44FB-8E5D-14D27D5F5B5CQ33414957-3EE7104F-6C8C-4A7F-AFE1-2CB8F6A00BDCQ33436604-E34F84AA-9C2C-4567-81EF-423673F03E66Q33560342-25313D8B-C6FC-48A9-A533-9789C93563CAQ33576711-B2E53AF3-BE40-44DE-8645-9DB116F7A3BCQ33585122-C202B818-2617-4E7F-9E18-18E918416CC3Q33588053-C1E34C8B-D9A6-463C-BF3B-912D48F8348CQ33588914-897F6B49-A98B-4BB9-BF73-0D1E817B7C3EQ33610694-342B0592-31E4-4DE0-8EC5-6F9FA8CD7DF8Q33698419-E79DFD3D-ECC7-4395-957C-E036B56EE7BFQ33702404-63821697-8DCC-45A5-8391-513168BBAEFAQ33710875-CC3CE621-3121-4581-8CDD-A49FE0D36562Q33727755-914840D5-203A-4CC4-9EAC-433A2D1FF53AQ33737225-818986E7-FD59-4BFB-BC08-474F17674F83Q33772238-4CB5C637-3F8C-4797-8FF8-4B1D21711F5BQ33794256-43364C11-F405-415C-B2AD-7226495A6847Q33805412-37A079DE-6333-4000-8F9B-FB5995D9D774Q33864287-4E166D53-17FB-4659-A95C-B1898BE38D82Q33899286-70CCA866-DD93-4A0A-9A34-BBE9B00CFA4BQ33908782-34C63E99-93FE-4EDB-876D-87CFA7F575D2Q34071671-3CE98C04-E8D3-48B0-9024-ADD28B8FFEFDQ34124213-291BB44A-3731-4A78-B08B-3D7FC55D2F99Q34124728-E80E4B31-6B97-4144-99DC-2FF8DFC3933DQ34131899-B492B6DA-AC84-4910-8D48-73801AD40811
P2860
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Proteinuria, a target for reno ...... hropathy: lessons from RENAAL.
@en
type
label
Proteinuria, a target for reno ...... hropathy: lessons from RENAAL.
@en
prefLabel
Proteinuria, a target for reno ...... hropathy: lessons from RENAAL.
@en
P2093
P1433
P1476
Proteinuria, a target for reno ...... hropathy: lessons from RENAAL.
@en
P2093
Barry M Brenner
Dick de Zeeuw
Hans-Henrik Parving
Mark E Cooper
Shahnaz Shahinfar
Steve Snapinn
William E Mitch
William F Keane
Zhongxin Zhang
P304
P356
10.1111/J.1523-1755.2004.00653.X
P407
P577
2004-06-01T00:00:00Z
P5875
P6179
1044734909